Beyond Insulin: DNA Technology Offers Potential Treatment for Type 1 Diabetes

Published on 11 Jul, 2025

As DNA technology continues to evolve, the dream of an insulin-free future for individuals living with Type 1 diabetes is becoming more tangible.


Read more
Decide Fearlessly
Aranca is a global research analytics and advisory firm with over 20 years of experience in helping organizations take strategic business and investment decisions fearlessly and with utmost conviction.
Connect with us
Reach out to us

© , Aranca. All rights reserved.